Concepts (361)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthroplasty, Replacement, Knee | 73 | 2023 | 615 | 15.230 |
Why?
|
| Arthroplasty, Replacement, Hip | 48 | 2023 | 790 | 10.210 |
Why?
|
| Knee Prosthesis | 28 | 2023 | 222 | 8.730 |
Why?
|
| Knee Joint | 42 | 2022 | 758 | 6.290 |
Why?
|
| Hip Prosthesis | 26 | 2023 | 531 | 6.290 |
Why?
|
| Femur | 20 | 2020 | 383 | 4.670 |
Why?
|
| Surgery, Computer-Assisted | 16 | 2017 | 54 | 4.580 |
Why?
|
| Prosthesis Failure | 24 | 2023 | 506 | 3.650 |
Why?
|
| Prosthesis Design | 28 | 2023 | 482 | 3.310 |
Why?
|
| Osteoarthritis, Knee | 20 | 2019 | 359 | 3.250 |
Why?
|
| Tibia | 17 | 2019 | 256 | 3.060 |
Why?
|
| Hip Joint | 17 | 2017 | 442 | 2.960 |
Why?
|
| Middle Aged | 80 | 2021 | 8601 | 2.910 |
Why?
|
| Retrospective Studies | 55 | 2022 | 3367 | 2.680 |
Why?
|
| Reoperation | 25 | 2023 | 879 | 2.620 |
Why?
|
| Bone Cements | 7 | 2023 | 88 | 2.590 |
Why?
|
| Aged | 70 | 2021 | 8765 | 2.510 |
Why?
|
| Humans | 123 | 2023 | 26286 | 2.480 |
Why?
|
| Postoperative Period | 22 | 2020 | 312 | 2.250 |
Why?
|
| Female | 82 | 2022 | 14539 | 2.250 |
Why?
|
| Male | 81 | 2022 | 14162 | 2.240 |
Why?
|
| Pain, Postoperative | 11 | 2020 | 309 | 2.000 |
Why?
|
| Postoperative Complications | 15 | 2022 | 869 | 1.950 |
Why?
|
| Osteoarthritis, Hip | 5 | 2018 | 99 | 1.760 |
Why?
|
| Patient Satisfaction | 8 | 2019 | 311 | 1.760 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2017 | 723 | 1.710 |
Why?
|
| Metal-on-Metal Joint Prostheses | 5 | 2017 | 50 | 1.700 |
Why?
|
| Prospective Studies | 21 | 2020 | 1668 | 1.630 |
Why?
|
| Treatment Outcome | 31 | 2023 | 3391 | 1.580 |
Why?
|
| Acetabulum | 6 | 2016 | 210 | 1.580 |
Why?
|
| Bone Malalignment | 7 | 2014 | 19 | 1.540 |
Why?
|
| Adult | 38 | 2019 | 7448 | 1.540 |
Why?
|
| Anticoagulants | 4 | 2015 | 89 | 1.480 |
Why?
|
| Venous Thromboembolism | 3 | 2015 | 36 | 1.440 |
Why?
|
| Joint Diseases | 4 | 2016 | 108 | 1.390 |
Why?
|
| Radiography | 20 | 2017 | 616 | 1.340 |
Why?
|
| Range of Motion, Articular | 15 | 2017 | 693 | 1.330 |
Why?
|
| Magnetic Resonance Imaging | 9 | 2017 | 1157 | 1.260 |
Why?
|
| Recovery of Function | 11 | 2016 | 283 | 1.240 |
Why?
|
| Noise | 3 | 2017 | 21 | 1.230 |
Why?
|
| Warfarin | 4 | 2015 | 26 | 1.200 |
Why?
|
| Bone Density | 3 | 2018 | 142 | 1.160 |
Why?
|
| Imaging, Three-Dimensional | 9 | 2016 | 218 | 1.140 |
Why?
|
| Chromium | 3 | 2016 | 88 | 1.110 |
Why?
|
| Cobalt | 3 | 2016 | 110 | 1.090 |
Why?
|
| Metals | 4 | 2017 | 142 | 1.080 |
Why?
|
| Prosthesis-Related Infections | 5 | 2020 | 184 | 1.070 |
Why?
|
| Aspirin | 3 | 2015 | 78 | 1.040 |
Why?
|
| Foreign-Body Reaction | 2 | 2017 | 26 | 1.040 |
Why?
|
| Venous Thrombosis | 2 | 2015 | 44 | 0.940 |
Why?
|
| Osteolysis | 2 | 2017 | 138 | 0.920 |
Why?
|
| Titanium | 4 | 2020 | 172 | 0.880 |
Why?
|
| Arthritis | 4 | 2020 | 52 | 0.870 |
Why?
|
| Aged, 80 and over | 18 | 2019 | 4675 | 0.840 |
Why?
|
| Biomechanical Phenomena | 11 | 2017 | 639 | 0.840 |
Why?
|
| Cholecalciferol | 1 | 2022 | 6 | 0.830 |
Why?
|
| Synovial Fluid | 2 | 2020 | 93 | 0.830 |
Why?
|
| Hip Dislocation | 6 | 2023 | 65 | 0.820 |
Why?
|
| Negative-Pressure Wound Therapy | 2 | 2021 | 3 | 0.800 |
Why?
|
| Arthroplasty, Replacement | 4 | 2013 | 146 | 0.780 |
Why?
|
| Age Factors | 9 | 2018 | 753 | 0.780 |
Why?
|
| Surveys and Questionnaires | 9 | 2019 | 1074 | 0.770 |
Why?
|
| Accelerometry | 2 | 2012 | 87 | 0.760 |
Why?
|
| Surgical Wound | 2 | 2018 | 10 | 0.760 |
Why?
|
| Surgical Wound Infection | 3 | 2021 | 82 | 0.740 |
Why?
|
| Registries | 2 | 2018 | 177 | 0.710 |
Why?
|
| Pain Measurement | 4 | 2016 | 454 | 0.700 |
Why?
|
| Specimen Handling | 1 | 2020 | 40 | 0.690 |
Why?
|
| Lower Extremity | 3 | 2015 | 38 | 0.690 |
Why?
|
| Periprosthetic Fractures | 1 | 2020 | 26 | 0.680 |
Why?
|
| Incidence | 9 | 2018 | 716 | 0.650 |
Why?
|
| Equipment Failure Analysis | 4 | 2014 | 101 | 0.640 |
Why?
|
| Computer-Aided Design | 2 | 2016 | 15 | 0.640 |
Why?
|
| Joint Dislocations | 3 | 2023 | 56 | 0.640 |
Why?
|
| Intermittent Pneumatic Compression Devices | 2 | 2015 | 7 | 0.610 |
Why?
|
| Research Design | 3 | 2015 | 183 | 0.610 |
Why?
|
| Acceleration | 3 | 2012 | 19 | 0.600 |
Why?
|
| Ankle Joint | 5 | 2016 | 43 | 0.580 |
Why?
|
| Severity of Illness Index | 6 | 2019 | 936 | 0.570 |
Why?
|
| Risk Factors | 9 | 2022 | 2265 | 0.570 |
Why?
|
| Genu Varum | 1 | 2017 | 4 | 0.570 |
Why?
|
| Weight-Bearing | 2 | 2014 | 163 | 0.560 |
Why?
|
| Cadaver | 4 | 2012 | 370 | 0.560 |
Why?
|
| Risk Assessment | 3 | 2018 | 629 | 0.560 |
Why?
|
| Pelvic Bones | 1 | 2016 | 17 | 0.550 |
Why?
|
| Patient Reported Outcome Measures | 3 | 2019 | 495 | 0.540 |
Why?
|
| Femur Neck | 1 | 2016 | 17 | 0.530 |
Why?
|
| Supine Position | 1 | 2016 | 17 | 0.530 |
Why?
|
| Young Adult | 10 | 2019 | 1886 | 0.530 |
Why?
|
| Prosthesis Fitting | 2 | 2013 | 21 | 0.530 |
Why?
|
| Analgesics, Opioid | 6 | 2020 | 210 | 0.520 |
Why?
|
| Posture | 4 | 2017 | 63 | 0.520 |
Why?
|
| Patient Discharge | 3 | 2019 | 147 | 0.510 |
Why?
|
| Hypersensitivity | 1 | 2016 | 39 | 0.510 |
Why?
|
| Orthopedic Procedures | 1 | 2018 | 309 | 0.480 |
Why?
|
| International Normalized Ratio | 1 | 2014 | 19 | 0.480 |
Why?
|
| Osteoarthritis | 2 | 2016 | 316 | 0.450 |
Why?
|
| Patella | 1 | 2014 | 70 | 0.440 |
Why?
|
| Reproducibility of Results | 6 | 2019 | 679 | 0.440 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 72 | 0.440 |
Why?
|
| Leg Length Inequality | 1 | 2013 | 9 | 0.430 |
Why?
|
| Fibrosis | 1 | 2013 | 26 | 0.430 |
Why?
|
| Patellofemoral Joint | 1 | 2014 | 66 | 0.420 |
Why?
|
| Missouri | 4 | 2016 | 27 | 0.420 |
Why?
|
| Time Factors | 8 | 2019 | 1391 | 0.420 |
Why?
|
| Computer Simulation | 2 | 2016 | 196 | 0.410 |
Why?
|
| Stereotaxic Techniques | 1 | 2012 | 19 | 0.410 |
Why?
|
| Muscular Diseases | 1 | 2012 | 13 | 0.400 |
Why?
|
| Anti-Bacterial Agents | 4 | 2018 | 339 | 0.390 |
Why?
|
| United States | 9 | 2018 | 1990 | 0.390 |
Why?
|
| Blood Transfusion | 4 | 2022 | 65 | 0.380 |
Why?
|
| Lumbar Vertebrae | 1 | 2016 | 411 | 0.380 |
Why?
|
| Rotation | 4 | 2014 | 129 | 0.370 |
Why?
|
| Viscosity | 4 | 2019 | 9 | 0.370 |
Why?
|
| Porosity | 2 | 2022 | 59 | 0.370 |
Why?
|
| Pain | 4 | 2019 | 389 | 0.360 |
Why?
|
| Osteoporosis | 1 | 2011 | 79 | 0.360 |
Why?
|
| Adolescent | 6 | 2019 | 2080 | 0.350 |
Why?
|
| Joint Prosthesis | 4 | 2019 | 82 | 0.340 |
Why?
|
| Follow-Up Studies | 7 | 2021 | 1738 | 0.340 |
Why?
|
| Patient Positioning | 4 | 2017 | 40 | 0.340 |
Why?
|
| Cartilage, Articular | 1 | 2014 | 413 | 0.330 |
Why?
|
| Spinal Fusion | 1 | 2016 | 480 | 0.330 |
Why?
|
| Rotator Cuff | 1 | 2012 | 297 | 0.320 |
Why?
|
| Length of Stay | 5 | 2019 | 304 | 0.320 |
Why?
|
| Body Mass Index | 4 | 2020 | 427 | 0.310 |
Why?
|
| Femur Head | 4 | 2023 | 60 | 0.300 |
Why?
|
| Enterocolitis, Pseudomembranous | 2 | 2018 | 11 | 0.300 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2019 | 252 | 0.300 |
Why?
|
| Chi-Square Distribution | 3 | 2016 | 134 | 0.290 |
Why?
|
| Joint Instability | 4 | 2019 | 392 | 0.290 |
Why?
|
| Arthroscopy | 2 | 2014 | 974 | 0.290 |
Why?
|
| Corrosion | 3 | 2017 | 126 | 0.280 |
Why?
|
| Absorptiometry, Photon | 2 | 2018 | 79 | 0.280 |
Why?
|
| Arthroplasty, Replacement, Elbow | 2 | 2019 | 7 | 0.280 |
Why?
|
| Osteocytes | 2 | 2019 | 18 | 0.280 |
Why?
|
| Polyethylene | 4 | 2019 | 120 | 0.270 |
Why?
|
| Blood Loss, Surgical | 2 | 2020 | 55 | 0.270 |
Why?
|
| Hip Fractures | 2 | 2018 | 26 | 0.270 |
Why?
|
| Sex Factors | 3 | 2017 | 450 | 0.260 |
Why?
|
| Patient Readmission | 3 | 2018 | 128 | 0.260 |
Why?
|
| Pain Management | 4 | 2020 | 137 | 0.260 |
Why?
|
| Elbow Joint | 2 | 2019 | 125 | 0.250 |
Why?
|
| Cytokines | 2 | 2019 | 226 | 0.250 |
Why?
|
| Hemorrhage | 2 | 2015 | 78 | 0.250 |
Why?
|
| Hand | 2 | 2018 | 38 | 0.250 |
Why?
|
| Awards and Prizes | 2 | 2016 | 21 | 0.240 |
Why?
|
| Stress, Mechanical | 3 | 2014 | 160 | 0.230 |
Why?
|
| Comorbidity | 2 | 2022 | 475 | 0.220 |
Why?
|
| Cohort Studies | 4 | 2020 | 1838 | 0.220 |
Why?
|
| Double-Blind Method | 2 | 2022 | 400 | 0.220 |
Why?
|
| Therapeutic Irrigation | 2 | 2020 | 57 | 0.220 |
Why?
|
| Urinary Retention | 1 | 2022 | 10 | 0.210 |
Why?
|
| Gait | 2 | 2017 | 408 | 0.210 |
Why?
|
| Patient Selection | 2 | 2014 | 194 | 0.210 |
Why?
|
| Time and Motion Studies | 1 | 2022 | 17 | 0.210 |
Why?
|
| Urinary Tract Infections | 1 | 2022 | 29 | 0.210 |
Why?
|
| Dietary Supplements | 1 | 2022 | 55 | 0.200 |
Why?
|
| Opioid-Related Disorders | 2 | 2020 | 47 | 0.200 |
Why?
|
| Algorithms | 3 | 2019 | 366 | 0.200 |
Why?
|
| Vitamin D | 1 | 2022 | 38 | 0.200 |
Why?
|
| Equipment Design | 2 | 2012 | 144 | 0.190 |
Why?
|
| Cementation | 1 | 2021 | 33 | 0.190 |
Why?
|
| Postural Balance | 1 | 2022 | 117 | 0.190 |
Why?
|
| Surface Properties | 2 | 2019 | 130 | 0.180 |
Why?
|
| Orthopedics | 2 | 2013 | 116 | 0.180 |
Why?
|
| Refuse Disposal | 1 | 2020 | 2 | 0.180 |
Why?
|
| Antifibrinolytic Agents | 1 | 2020 | 17 | 0.180 |
Why?
|
| Tranexamic Acid | 1 | 2020 | 17 | 0.180 |
Why?
|
| Leukocyte Count | 1 | 2020 | 64 | 0.180 |
Why?
|
| Prescriptions | 1 | 2020 | 17 | 0.170 |
Why?
|
| Acetaminophen | 1 | 2020 | 22 | 0.170 |
Why?
|
| Los Angeles | 2 | 2017 | 7 | 0.170 |
Why?
|
| Osteoclasts | 1 | 2019 | 19 | 0.170 |
Why?
|
| Tertiary Care Centers | 1 | 2020 | 63 | 0.170 |
Why?
|
| Arthroplasty | 2 | 2018 | 145 | 0.170 |
Why?
|
| Neutrophils | 1 | 2020 | 96 | 0.170 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2019 | 162 | 0.170 |
Why?
|
| Pain Perception | 1 | 2019 | 4 | 0.160 |
Why?
|
| Cell Differentiation | 1 | 2019 | 124 | 0.160 |
Why?
|
| Wound Healing | 2 | 2018 | 149 | 0.160 |
Why?
|
| Pelvis | 2 | 2016 | 30 | 0.160 |
Why?
|
| Oxycodone | 1 | 2019 | 4 | 0.160 |
Why?
|
| Patient Education as Topic | 1 | 2020 | 140 | 0.160 |
Why?
|
| Survivorship | 1 | 2019 | 21 | 0.160 |
Why?
|
| Mobile Applications | 1 | 2019 | 24 | 0.160 |
Why?
|
| Drug Prescriptions | 1 | 2019 | 25 | 0.160 |
Why?
|
| Apoptosis | 1 | 2019 | 195 | 0.160 |
Why?
|
| Physical Therapy Modalities | 1 | 2019 | 71 | 0.160 |
Why?
|
| alpha-Defensins | 1 | 2018 | 3 | 0.160 |
Why?
|
| Ceramics | 2 | 2015 | 22 | 0.160 |
Why?
|
| Morphine | 1 | 2019 | 62 | 0.150 |
Why?
|
| Logistic Models | 2 | 2016 | 365 | 0.150 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2018 | 7 | 0.150 |
Why?
|
| Surgeons | 2 | 2019 | 79 | 0.150 |
Why?
|
| Bone Remodeling | 1 | 2018 | 46 | 0.150 |
Why?
|
| Databases, Factual | 2 | 2018 | 333 | 0.150 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2019 | 104 | 0.150 |
Why?
|
| Drainage | 1 | 2018 | 46 | 0.150 |
Why?
|
| Preoperative Period | 2 | 2020 | 78 | 0.150 |
Why?
|
| Arthritis, Infectious | 1 | 2018 | 53 | 0.150 |
Why?
|
| Knee | 1 | 2017 | 43 | 0.140 |
Why?
|
| Spine | 1 | 2018 | 111 | 0.140 |
Why?
|
| Motion | 1 | 2016 | 21 | 0.140 |
Why?
|
| Mupirocin | 1 | 2016 | 17 | 0.140 |
Why?
|
| Sacrum | 1 | 2016 | 24 | 0.140 |
Why?
|
| Fascia Lata | 1 | 2016 | 12 | 0.140 |
Why?
|
| Ions | 1 | 2016 | 54 | 0.140 |
Why?
|
| Thigh | 1 | 2016 | 32 | 0.140 |
Why?
|
| Patient Outcome Assessment | 1 | 2016 | 39 | 0.130 |
Why?
|
| Auditory Perception | 1 | 2016 | 30 | 0.130 |
Why?
|
| Rats | 2 | 2019 | 618 | 0.130 |
Why?
|
| Chlorhexidine | 1 | 2016 | 56 | 0.130 |
Why?
|
| Stockings, Compression | 1 | 2015 | 2 | 0.130 |
Why?
|
| Midwestern United States | 1 | 2016 | 62 | 0.130 |
Why?
|
| Internal Fixators | 1 | 2016 | 38 | 0.130 |
Why?
|
| Tennessee | 1 | 2015 | 9 | 0.130 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 305 | 0.130 |
Why?
|
| Preoperative Care | 2 | 2014 | 122 | 0.130 |
Why?
|
| Great Lakes Region | 1 | 2015 | 1 | 0.130 |
Why?
|
| Vulnerable Populations | 1 | 2015 | 24 | 0.120 |
Why?
|
| Joint Capsule | 2 | 2012 | 46 | 0.120 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 574 | 0.120 |
Why?
|
| Pulmonary Embolism | 1 | 2015 | 61 | 0.120 |
Why?
|
| Alloys | 1 | 2015 | 92 | 0.120 |
Why?
|
| Regional Health Planning | 1 | 2014 | 4 | 0.120 |
Why?
|
| Chemoprevention | 1 | 2014 | 4 | 0.120 |
Why?
|
| Patients | 1 | 2015 | 31 | 0.120 |
Why?
|
| Drug Monitoring | 1 | 2014 | 17 | 0.120 |
Why?
|
| Perception | 1 | 2015 | 74 | 0.120 |
Why?
|
| Software | 1 | 2014 | 65 | 0.120 |
Why?
|
| Arthritis, Juvenile | 1 | 2014 | 7 | 0.120 |
Why?
|
| Knee Dislocation | 1 | 2014 | 4 | 0.120 |
Why?
|
| Femoral Nerve | 1 | 2014 | 9 | 0.120 |
Why?
|
| Survival Rate | 1 | 2015 | 322 | 0.120 |
Why?
|
| Sexual Behavior | 1 | 2014 | 50 | 0.120 |
Why?
|
| Amides | 1 | 2014 | 16 | 0.120 |
Why?
|
| Shoulder Joint | 2 | 2012 | 642 | 0.120 |
Why?
|
| Obesity | 1 | 2017 | 279 | 0.120 |
Why?
|
| Hip Dislocation, Congenital | 1 | 2014 | 4 | 0.110 |
Why?
|
| Analgesia, Epidural | 1 | 2014 | 52 | 0.110 |
Why?
|
| Disability Evaluation | 1 | 2016 | 290 | 0.110 |
Why?
|
| Patellar Ligament | 1 | 2014 | 42 | 0.110 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 191 | 0.110 |
Why?
|
| Fluoroscopy | 1 | 2013 | 53 | 0.110 |
Why?
|
| Anesthetics, Local | 1 | 2014 | 81 | 0.110 |
Why?
|
| Connective Tissue | 1 | 2013 | 21 | 0.110 |
Why?
|
| Nerve Block | 1 | 2014 | 63 | 0.110 |
Why?
|
| Case-Control Studies | 1 | 2014 | 566 | 0.110 |
Why?
|
| Pressure | 1 | 2013 | 55 | 0.110 |
Why?
|
| Leg | 1 | 2013 | 48 | 0.100 |
Why?
|
| Hip | 1 | 2013 | 48 | 0.100 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 460 | 0.100 |
Why?
|
| Pregnancy | 1 | 2013 | 310 | 0.100 |
Why?
|
| Femoral Neck Fractures | 1 | 2012 | 11 | 0.100 |
Why?
|
| Foreign-Body Migration | 1 | 2012 | 19 | 0.100 |
Why?
|
| Confidence Intervals | 1 | 2012 | 90 | 0.100 |
Why?
|
| Vasculitis | 1 | 2012 | 26 | 0.100 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2013 | 326 | 0.100 |
Why?
|
| Societies, Medical | 1 | 2013 | 146 | 0.100 |
Why?
|
| Chromium Alloys | 1 | 2012 | 43 | 0.100 |
Why?
|
| Ultrasonography | 1 | 2014 | 222 | 0.100 |
Why?
|
| Statistics as Topic | 1 | 2012 | 110 | 0.100 |
Why?
|
| Lymphocytes | 1 | 2012 | 59 | 0.100 |
Why?
|
| Quality of Life | 1 | 2017 | 621 | 0.100 |
Why?
|
| Hemiarthroplasty | 1 | 2012 | 35 | 0.100 |
Why?
|
| Arthritis, Psoriatic | 1 | 2012 | 14 | 0.100 |
Why?
|
| Intraoperative Period | 1 | 2011 | 25 | 0.100 |
Why?
|
| Computers, Handheld | 1 | 2011 | 11 | 0.100 |
Why?
|
| Exercise | 1 | 2016 | 451 | 0.100 |
Why?
|
| Analysis of Variance | 1 | 2012 | 252 | 0.100 |
Why?
|
| Patellar Dislocation | 1 | 2012 | 23 | 0.100 |
Why?
|
| External Fixators | 1 | 2011 | 10 | 0.100 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2011 | 32 | 0.100 |
Why?
|
| Educational Measurement | 1 | 2011 | 53 | 0.090 |
Why?
|
| Arthralgia | 1 | 2012 | 115 | 0.090 |
Why?
|
| Health Status | 1 | 2012 | 215 | 0.090 |
Why?
|
| Movement | 1 | 2011 | 110 | 0.090 |
Why?
|
| Shoulder Injuries | 1 | 2012 | 148 | 0.090 |
Why?
|
| Signal Transduction | 1 | 2013 | 409 | 0.090 |
Why?
|
| Cross-Sectional Studies | 1 | 2013 | 853 | 0.090 |
Why?
|
| Athletic Injuries | 1 | 2012 | 167 | 0.090 |
Why?
|
| Cost-Benefit Analysis | 3 | 2016 | 126 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2012 | 374 | 0.090 |
Why?
|
| Animals | 2 | 2019 | 3538 | 0.090 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2009 | 39 | 0.080 |
Why?
|
| Internship and Residency | 1 | 2011 | 206 | 0.080 |
Why?
|
| Rotator Cuff Injuries | 1 | 2012 | 314 | 0.080 |
Why?
|
| Risk | 2 | 2019 | 199 | 0.070 |
Why?
|
| Elective Surgical Procedures | 2 | 2019 | 37 | 0.070 |
Why?
|
| Early Ambulation | 2 | 2019 | 17 | 0.070 |
Why?
|
| Odds Ratio | 2 | 2019 | 265 | 0.070 |
Why?
|
| Medicare | 2 | 2015 | 114 | 0.060 |
Why?
|
| Urinary Catheters | 1 | 2022 | 4 | 0.050 |
Why?
|
| Urinary Catheterization | 1 | 2022 | 7 | 0.050 |
Why?
|
| Catheters | 1 | 2022 | 17 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2018 | 485 | 0.050 |
Why?
|
| Silver | 1 | 2021 | 4 | 0.050 |
Why?
|
| Bandages | 1 | 2021 | 7 | 0.050 |
Why?
|
| Drug Administration Schedule | 1 | 2020 | 156 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2020 | 38 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2020 | 105 | 0.040 |
Why?
|
| Benzodiazepines | 1 | 2020 | 45 | 0.040 |
Why?
|
| Bone-Implant Interface | 1 | 2019 | 7 | 0.040 |
Why?
|
| Povidone-Iodine | 1 | 2019 | 5 | 0.040 |
Why?
|
| Antidepressive Agents | 1 | 2020 | 93 | 0.040 |
Why?
|
| X-Ray Microtomography | 1 | 2019 | 85 | 0.040 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 98 | 0.040 |
Why?
|
| Bone Resorption | 1 | 2019 | 83 | 0.040 |
Why?
|
| Demography | 1 | 2019 | 71 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2019 | 264 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 338 | 0.040 |
Why?
|
| Body Weight | 1 | 2019 | 121 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2019 | 253 | 0.040 |
Why?
|
| Analgesics | 1 | 2019 | 79 | 0.040 |
Why?
|
| Inpatients | 1 | 2019 | 135 | 0.040 |
Why?
|
| Colitis | 1 | 2017 | 36 | 0.040 |
Why?
|
| Smoking | 1 | 2018 | 170 | 0.030 |
Why?
|
| Administration, Intranasal | 1 | 2016 | 25 | 0.030 |
Why?
|
| Staphylococcus aureus | 1 | 2016 | 62 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2020 | 561 | 0.030 |
Why?
|
| Hospital Costs | 1 | 2016 | 65 | 0.030 |
Why?
|
| Quality Improvement | 1 | 2017 | 151 | 0.030 |
Why?
|
| Robotic Surgical Procedures | 1 | 2016 | 25 | 0.030 |
Why?
|
| Precision Medicine | 1 | 2015 | 25 | 0.030 |
Why?
|
| Biomarkers | 1 | 2018 | 556 | 0.030 |
Why?
|
| Medicaid | 1 | 2015 | 36 | 0.030 |
Why?
|
| Risk Reduction Behavior | 1 | 2015 | 46 | 0.030 |
Why?
|
| Spain | 1 | 2014 | 9 | 0.030 |
Why?
|
| Delphi Technique | 1 | 2014 | 23 | 0.030 |
Why?
|
| Anatomic Landmarks | 1 | 2014 | 5 | 0.030 |
Why?
|
| Zirconium | 1 | 2014 | 5 | 0.030 |
Why?
|
| Staphylococcal Infections | 1 | 2016 | 150 | 0.030 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2014 | 19 | 0.030 |
Why?
|
| Aluminum Oxide | 1 | 2014 | 7 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 2015 | 123 | 0.030 |
Why?
|
| Observer Variation | 1 | 2014 | 93 | 0.030 |
Why?
|
| Infusions, Parenteral | 1 | 2014 | 9 | 0.030 |
Why?
|
| New York City | 1 | 2014 | 14 | 0.030 |
Why?
|
| Health Surveys | 1 | 2014 | 84 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2017 | 361 | 0.030 |
Why?
|
| Hospitals | 1 | 2015 | 150 | 0.030 |
Why?
|
| Health Care Costs | 1 | 2015 | 66 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2015 | 291 | 0.030 |
Why?
|
| Device Removal | 1 | 2014 | 83 | 0.030 |
Why?
|
| Biocompatible Materials | 1 | 2014 | 90 | 0.030 |
Why?
|
| Linear Models | 1 | 2014 | 239 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2015 | 165 | 0.030 |
Why?
|
| Accidental Falls | 1 | 2014 | 113 | 0.030 |
Why?
|
| Fingers | 1 | 2012 | 9 | 0.020 |
Why?
|
| Dermatologic Agents | 1 | 2012 | 7 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2012 | 75 | 0.020 |
Why?
|
| Recurrence | 1 | 2012 | 314 | 0.020 |
Why?
|
| Antirheumatic Agents | 1 | 2012 | 86 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2012 | 186 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2012 | 192 | 0.020 |
Why?
|
| Models, Biological | 1 | 2012 | 306 | 0.020 |
Why?
|
| Probability | 1 | 2009 | 85 | 0.020 |
Why?
|
| Polyethylenes | 1 | 2009 | 37 | 0.020 |
Why?
|
| Materials Testing | 1 | 2009 | 132 | 0.020 |
Why?
|
| Child | 1 | 2012 | 1236 | 0.020 |
Why?
|